Mutation Patterns Underlie Cancers

More than 20 genome-wide mutational “signatures” account for the vast majority of 30 common cancers.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, THE ARMED FORCES INSTITUTE OF PATHOLOGYCancers possess a combination of distinct mutational patterns, each of which is an “imprint left on the cancer genome by a mutational process,” according to a study published in Nature this week (August 14). “We have uncovered the archaeological traces within cancer genomes of the diverse mutational processes that lead to the development of most cancers,” Mike Stratton, senior author of the study and the director of the Wellcome Trust Sanger Institute in Cambridgeshire, U.K., said in a press release. Many of these patterns are linked to known mutagens, such as cigarette smoke and UV light. Other mutation combinations, however, don't have clear causes identified just yet, opening opportunities to dig up potentially novel mechanisms of cancer development.

A large, international team scoured the genomes of 7,042 cancers and analyzed nearly 5,000,000 mutations. The researchers found 21 mutation patterns that popped up, in varying degrees, in each of the 30 different cancer types analyzed. One mutational signature, which the researchers termed Signature 1B, was present in the greatest number of cancer types—19. Others were less common; Signature 21, for example, appeared only in stomach cancer.

Every type of cancer the researchers studied had at least two mutational signatures. Liver, stomach, and uterine cancers each showed six mutation signatures.

Some of the mutation patterns had clear associations with known cancer causes, including environmental carcinogens. “Abnormalities in DNA maintenance may also be responsible for mutational signatures,” the authors wrote in their report. They attributed two ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies